Konference om sanktioner og eksportoverholdelse inden for biovidenskab
Sanctions and Export Compliance in Life Sciences Conference, 11 - 12 March 2026, Zurich, Switzerland
Vores konference fokuserer på sanktioner, eksportkontrol og overholdelse af toldregler i sektorerne for lægemidler, bioteknologi og medicinsk udstyr.
The Sanctions and Export Compliance in Life Sciences Conference focuses on sanctions, export controls, and customs compliance within the pharmaceutical, biotechnology, and medical device sectors.
A successful conference is centered on delegate participation; at Nielsonsmith, we strive to build a platform where delegates can openly discuss the matter at hand in a room full of peers. In-depth presentations with extended Q&A time to get the answers uppermost in your mind.
- Ms. Fatimah Sajjadi, Trade Sanctions and Anti-Money Laundering Director, STADA
- Mr. Roberto Fuster Canales, Head of Global Trade Governance & Export Control, Boehringer Ingelheim
- Mr. Michel van den Hoven, Head of Global Trade Compliance, Philips
- Ms. Erika Trujillo, Director, Strategy & Development, SEIA
- Mr. Florian WolfPartner, Blomstein
- Mr. Tobias Ackermann, Senior Associate, Blomstein
- Ms. Nora Bartos, Legal Counsel Export Control & Economic Sanctions, Roche
- Mr. Nicholas Bentley, Head of Legal Trade Sanctions, Novartis
- Mr. Petar Ljujic, Senior Director, Global Trade Compliance EMEA, Siemens Healthineers
- Ms. Beata Kasperowicz, Senior Trade Compliance Manager, Alcon
- Mr. Tobias Bergbauer, Head of Customs and Export Control, Olympus
- Mr. Kostas Katsoulis, Director, Global Trade Compliance, Solventum
Kontakt din NielsonSmith-repræsentant for at drøfte programmet mere indgående.
Day 1
08:15 - 09:00 Registrering åbner og morgenforfriskninger
09:00 – 09:20 Chairman opening address and participants’ introductions
09:20– 10:20 Evolving EU Sanctions and Export Controls: Enforcement, Fragmentation, and Compliance Risks for Life Sciences
10:20 – 11:20 The Expiry of the JCPOA: Repercussions for Pharmaceutical Trade with Iran
11:20 – 11:45 Morning Refreshment break and networking
11:45 - 12:45 China’s Export Controls on Rare Earths and Critical Minerals: Implications for European Life Sciences
12:45 – 14:00 NETWORKING LUNCH
14:00 – 15:00 Panel Discussion: Post-Election U.S. Sanctions Landscape: Preparing for 2026 Policy Shifts
15:00 – 16:00 SEIA’s Top Trends in Regulatory and Operational Risks from Life Sciences in 2025
16:00 – 16:25 Afternoon Refreshment Break & Networking
16:25 – 17:25 Sustainability and Compliance: From the EUDR to ESG-Driven Due Diligence
17:25 – 17:30 Chairman’s Closing Remarks
17:30 – 18:30 Conference Networking Drinks Reception
DAY 2
08:30 - 08:55 Forfriskninger og networking tidligt om morgenen
08:55 - 09:00 Chairman opening remarks
09:00 – 11:00
STREAM 1: Medical Devices
STREAM 2: Pharma
11:00 – 11:25 Morning Refreshment break and networking
11:25 – 12:25 Digital and Trade Data at the Core of Compliance Transformation
12:25 – 13:40 NETWORKING LUNCH
13:40 – 14:40 Trade Barriers and Free Trade Agreements: New Opportunities for Life Sciences Companies
14:40 – 15:40 Supply Chain Resilience and Dual-Use Risks in Pharmaceuticals
15:40 – 16:00 Forfriskningspause og networking om eftermiddagen
16:00 – 16:50 Interaktive rundbordssamtaler om emner bragt op af de delegerede
16:50 - 17:00 Chairman remarks
END OF CONFERENCE
Hvis du er interesseret i at tale på denne konference, bedes du kontakte Miss Isra Mahmoud på isra.mahmoud@nielsonsmith.com
BLOMSTEIN is a leading boutique for international trade, antitrust, and public procurement law based in Berlin, Germany. Founded as a spin-off of a leading international law firm in 2016, BLOMSTEIN “has positioned itself at the top of the market within a few years,” according to clients and peers. The experienced team advises high-profile international clients in a broad range of sectors. Owing to their specific international trade law know-how, BLOMSTEIN was already awarded as “Law Firm of the Year / Foreign Trade Law” (JUVE Awards 2021). Alongside their expertise in export control, sanctions, and customs law, the team is particularly active in foreign direct investment control, assisting well-known clients with complex filings at the Federal Ministry for Economic Affairs and Climate Action (BMWK). BLOMSTEIN’s lawyers are well connected internationally. For seamless support worldwide, the firm cooperates with an excellent network of leading specialist firms in Germany and abroad.
På SEIA vi startede ikke med det mulige, vi startede med det, vi havde brug for, og arbejdede, indtil vi havde skabt nye muligheder. Vores løsninger transformerer fundamentalt, hvordan trade compliance udføres gennem state-of-the-art risikostyringsdashboards baseret på avanceret dataanalyse. Vores værktøjer er resultatet af innovation gennem samarbejde på tværs af brancher for at opnå et dashboard-system, der giver gennemsigtighed som aldrig før, brugbare brugercentrerede målinger og kritisk styring af SEIA's Risk RedFlags i realtid. Vi kan integrere med systemer fra hele din organisation (f.eks. handelsstyringssystemer, screeningssoftware eller andre compliance-programmer) for at sikre, at du får "gode data" på ét sted for at få den indsigt, du ønsker, og den risikosikring, du har brug for.
Should you wish to become our Partner at this event, please contact Miss Isra Mahmoud on isra.mahmoud@nielsonsmith.com
2-day physical pass for one person and the company-wide Post-Event Microsite license for 1 year – 1499 euros
Bemærk, at vi ikke opkræver moms af denne pris. Prisen inkluderer alle sessioner, frokost, forfriskninger og tilgængelig dokumentation. Venligst kontakt os for at få rabat på gruppebooking. Bemærk venligst: "Leverandør"-virksomheder kan kun deltage som sponsorer.
Konferencens mødested
Novotel Zurich City-WestZurich
Tildeling af indkvartering
TBC
Information
Deltagerbilletter er kun til interne deltagere. Compliance-leverandører kan kun deltage ved at blive sponsor, bedes du anmode om et prospekt via knappen nedenfor. Leverandører, der køber billetter, får ikke adgang til arrangementet og vil kun modtage en 70%-refusion.
